BIO-key International, Inc. (BKYI)
OTCMKTS · Delayed Price · Currency is USD
4.100
-0.400 (-8.89%)
At close: Jul 2, 2026
BIO-key International Earnings Call Transcripts
Fiscal Year 2026
-
The presentation highlighted strong growth in biometric authentication, driven by regulatory mandates and rising cybersecurity needs in regulated industries. Financial performance is improving, with profitability expected to be sustained, and the company is expanding through partners and innovation in AI and quantum-proof security.
-
Q1 2026 revenue grew 34% year-over-year, driven by defense and financial services wins, with gross margin steady at 82%. Management expects profitability in Q2 and is optimistic about relisting on Nasdaq following a June appeal.